Product Details for NDA 019710
OPTIRAY 300 (IOVERSOL)
64%
Marketing Status: Prescription
68%
Marketing Status: Prescription
74%
Marketing Status: Prescription
34%
Marketing Status: Discontinued
51%
Marketing Status: Discontinued
64%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 300
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 64%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 004
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
OPTIRAY 320 (IOVERSOL)
Proprietary Name: OPTIRAY 300
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 64%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 004
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
68%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 320
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 68%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 001
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
OPTIRAY 350 (IOVERSOL)
Proprietary Name: OPTIRAY 320
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 68%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 001
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
74%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 350
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 74%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 005
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
OPTIRAY 160 (IOVERSOL)
Proprietary Name: OPTIRAY 350
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 74%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N019710
Product Number: 005
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Prescription
Patent and Exclusivity Information
34%
Marketing Status: Discontinued
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 160
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 34%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019710
Product Number: 003
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
OPTIRAY 240 (IOVERSOL)
Proprietary Name: OPTIRAY 160
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 34%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019710
Product Number: 003
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
51%
Marketing Status: Discontinued
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 240
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 51%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019710
Product Number: 002
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: OPTIRAY 240
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 51%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019710
Product Number: 002
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status: Discontinued
Patent and Exclusivity Information